Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis

被引:126
作者
Weisman, MH
Furst, DE
Park, GS
Kremer, JM
Smith, KM
Wallace, DJ
Caldwell, JR
Dervieux, T
机构
[1] Proprius Pharmaceut, San Diego, CA 92130 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA
[4] Ctr Rheumatol, Albany, NY USA
[5] Prometheus Labs, San Diego, CA USA
[6] Radiat Res, Daytona Beach, FL USA
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 02期
关键词
D O I
10.1002/art.21573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Methotrexate (MTX) is an antifolate agent that is often associated with toxicity. This study investigated whether risk genotypes for folate-dependent enzymes are associated with the toxicity of MTX in patients with rheumatoid arthritis (RA). Methods. Blood was collected for analysis in a multicenter, cross-sectional study of RA patients who had been receiving MTX for at least 1 month prior to enrollment, and side effects occurring at the time of a single study visit were recorded. Low-penetrance risk genotypes in methylenetetrahydrofolate reductase (MTHFR) 677TT, thymidylate synthase (TSER) *2/*2 (variable number of tandem repeats), amino imidazole ribonucleotide transformylase (ATIC) 347GG, and serine hydroxymethyltransferase (SHMT1) 1420CC were measured and summed to constitute the toxicogenetic index specific to each patient. Statistical analyses consisted of logistic regression models with clustered-center effects, and associations with risk genotypes were expressed as adjusted odds ratios (ORs). Results. Among 214 patients enrolled at 4 study sites, a total of 67 patients (31%) presented with a side effect (gastrointestinal event, headache, lethargy, alopecia, cough, or dyspnea). Risk genotypes associated with side effects in the central nervous system were MTHFR 677TT (OR 3.3, P < 0.01) and SHMT1 1420CC (OR 2.4, P < 0.05). ATIC 347GG was associated with gastrointestinal side effects (OR 3.0, P < 0.01), while TSER *2/*2 (OR 5.4, P < 0.01) and SHMT1 1420CC (OR 3.2, P < 0.01) were associated with alopecia. The toxicogenetic index ranged from 0 to 3 (median 1). An index of 3 was associated with an similar to 7-fold higher likelihood of having a side effect compared with an index of 0 (P < 0.01). Conclusion. These data suggest that a composite index of the cumulative risk genotypes in folate-dependent enzymes may be an effective means of profiling RA patients who develop side effects to MTX.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 21 条
[1]  
[Anonymous], ARTHRITIS RHEUM
[2]   Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis [J].
Dervieux, T ;
Furst, D ;
Lein, DO ;
Capps, R ;
Smith, K ;
Walsh, M ;
Kremer, J .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2766-2774
[3]   HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis [J].
Dervieux, T ;
Lein, DO ;
Marcelletti, J ;
Pischel, K ;
Smith, K ;
Walsh, M ;
Richerson, R .
CLINICAL CHEMISTRY, 2003, 49 (10) :1632-1641
[4]  
ELSEA SH, 1995, AM J HUM GENET, V57, P1342
[5]   TEMPORARY REMISSIONS IN ACUTE LEUKEMIA IN CHILDREN PRODUCED BY FOLIC ACID ANTAGONIST, 4-AMINOPTEROYL-GLUTAMIC ACID (AMINOPTERIN) [J].
FARBER, S ;
DIAMOND, LK ;
MERCER, RD ;
SYLVESTER, RF ;
WOLFF, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1948, 238 (23) :787-793
[6]  
GUHNER R, 1951, AM J MED SCI, V221, P176
[7]   Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? [J].
Heil, SG ;
Van der Put, NMJ ;
Waas, ET ;
den Heijer, M ;
Trijbels, FJM ;
Blom, HJ .
MOLECULAR GENETICS AND METABOLISM, 2001, 73 (02) :164-172
[8]   Toward a better understanding of methotrexate [J].
Kremer, JM .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1370-1382
[9]   METHOTREXATE FOR RHEUMATOID-ARTHRITIS - SUGGESTED GUIDELINES FOR MONITORING LIVER TOXICITY [J].
KREMER, JM ;
ALARCON, GS ;
LIGHTFOOT, RW ;
WILLKENS, RF ;
FURST, DE ;
WILLIAMS, HJ ;
DENT, PB ;
WEINBLATT, ME .
ARTHRITIS AND RHEUMATISM, 1994, 37 (03) :316-328
[10]   THE SAFETY AND EFFICACY OF THE USE OF METHOTREXATE IN LONG-TERM THERAPY FOR RHEUMATOID-ARTHRITIS [J].
KREMER, JM ;
LEE, JK .
ARTHRITIS AND RHEUMATISM, 1986, 29 (07) :822-831